The growing interest in effective weight management has spurred considerable investigation into novel treatments. Currently, Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist , has exhibited promising results in pat